Q301--DONOR-DERIVED CELL FREE DNA TESTING
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Donor-Derived Cell-Free DNA (dd-cfDNA) Testing services to support the Renal Transplant Program at the James J. Peters VA Medical Center in Bronx, NY. The evaluated price for the awardee was $281,875.00, with a maximum ceiling of $600,000.00. This award, under a Full and Open competition, ensures comprehensive post-transplant surveillance for kidney transplant recipients.
Scope of Work
The awarded services encompass comprehensive, full-service Kidney Donor-Derived Cell-Free DNA (dd-cfDNA) Testing. Key deliverables include:
- Provision of specimen collection kits.
- Secure, trackable, and temperature-controlled transport of specimens to the testing laboratory within 48 hours.
- dd-cfDNA testing using CPT code 81479 in a CLIA-certified and CAP-accredited laboratory.
- Delivery of reliable and accurate test results within 72 hours of specimen receipt.
- Secure transmission of test results via fax or encrypted email, complying with HIPAA and PHI standards.
- Provision of training and clinical interpretation support to VA staff upon request.
- Maintenance of chain-of-custody documentation and adherence to a Quality Control Plan (QCP). The estimated annual testing volume is 30 to 45 dd-cfDNA tests.
Contract & Timeline
- Type: Indefinite Delivery/Indefinite Quantity (IDIQ), Firm-Fixed-Price (FFP)
- Duration: Five (5) years
- IDIQ Minimum: $1,000
- IDIQ Maximum: $600,000
- Evaluated Award Price: $281,875.00
- Set-Aside: Full and Open Competition
- NAICS Code: 621511 (Medical Laboratories)
- Award Date: April 1, 2026
Evaluation
The original solicitation for this award was evaluated based on Technical Capability, Past Performance, and Price. Technical Capability assessed understanding of requirements, specimen handling, testing procedures, laboratory qualifications (CLIA/CAP), quality control, and training support. Past Performance was evaluated based on relevance, recency (last 3 years), and quality. Price was evaluated for reasonableness and completeness.